copd
chronic
obstruct
pulmonari
diseas
esp
extracellular
serin
proteas
mrsa
staphylococcu
aureu
mssa
staphylococcu
aureu
otu
oper
taxonom
unit
tnf
tumor
necrosi
factor
urt
upper
respiratori
tract
studi
microbiota
began
discoveri
antoin
van
leeuwenhoek
centuri
ago
identif
differ
bacteria
dental
plaqu
earli
observ
indic
microbi
commun
influenc
develop
intestin
tract
includ
stimul
antibodi
product
potenti
benefici
bacteria
probiot
recent
studi
explor
complex
dynam
interact
influenc
extern
factor
diet
environ
gastrointestin
microbiota
implic
health
earliest
studi
also
indic
gener
pattern
success
influenc
commun
form
alter
via
invas
new
member
destabil
eg
antibiot
know
microbiota
contribut
nutrient
product
acquisit
well
resist
colon
pathogen
interestingli
studi
mice
demonstr
microbiota
requir
normal
physiolog
develop
organ
gut
lung
brain
gut
microbiota
drive
develop
mucos
immun
system
includ
initi
secret
immunoglobulin
develop
popul
stimul
product
antimicrobi
peptid
respiratori
tract
microbiota
less
well
studi
believ
also
contribut
local
immun
educ
develop
respiratori
diseas
includ
asthma
allergi
commun
upper
respiratori
tract
urt
microbiota
ie
sinus
nare
oropharyng
distinct
one
anoth
uniqu
pattern
colon
success
earli
infanc
urt
colon
sever
pathogen
includ
streptococcu
pneumonia
staphylococcu
aureu
haemophilu
influenza
bacteria
also
refer
pathobiont
gener
colon
host
asymptomat
potenti
caus
diseas
spread
site
colon
fact
pathobiont
streptococcu
anginosu
group
believ
major
caus
complic
lung
infect
pleural
empyema
composit
urt
microbiota
includ
presenc
pathogen
chang
rapidli
infanc
process
call
ecolog
success
ecolog
success
describ
chang
within
microbi
commun
time
influenc
chang
habitat
eg
develop
human
tissu
exposur
new
commun
member
ie
colon
bacteria
progress
urt
microbiota
shown
impact
airway
diseas
later
childhood
understand
microbi
success
colon
increas
reduc
suscept
respiratori
diseas
asthma
allergi
promot
prevent
invas
pathogen
may
inform
novel
intervent
review
describ
current
understand
urt
microbiota
influenc
health
infect
inflamm
nasopharyng
carriag
major
contributor
infect
relationship
carriag
rate
diseas
incid
antibiot
resist
monitor
swab
cultur
use
condit
enrich
specif
pathogen
exampl
st
aureu
often
detect
greater
individu
rate
carriag
st
aureu
mrsa
vari
wide
distinct
mrsa
st
aureu
mssa
import
colon
mrsa
increas
risk
invas
diseas
studi
davi
et
al
demonstr
upon
hospit
admiss
patient
mssa
carrier
patient
carri
mrsa
howev
much
higher
percentag
mrsa
carrier
develop
invas
staphylococc
diseas
mssa
carrier
monitor
colon
may
assist
prevent
infect
nasal
swab
also
use
measur
efficaci
vaccin
understand
interplay
age
environment
risk
factor
carriag
diseas
risk
exampl
result
vaccin
pneumonia
previous
common
serotyp
includ
vaccin
replac
nonvaccin
serotyp
overal
pneumonia
colon
gone
unchang
surveil
studi
found
vaccin
pneumonia
also
alter
carriag
st
aureu
h
influenza
limit
carriag
studi
provid
detail
data
specif
pathogen
less
help
understand
microbi
commun
whole
recent
studi
nasal
microbiota
assess
four
locat
along
length
nose
anterior
posterior
vestibul
middl
inferior
meatu
studi
taxa
domin
staphylococcu
corynebacterium
propionibacterium
speci
found
four
differ
site
surgic
patient
major
speci
found
region
nose
except
corynebacterium
simulan
present
posterior
vestibul
acinetobact
lwoffii
present
anterior
vestibul
inferior
meatu
distinct
pair
speci
gener
cultur
togeth
exampl
dolosigranulum
pigrum
cultur
sampl
corynebacterium
propinquum
staphylococcu
epidermidi
cultur
sampl
propionibacterium
acn
suggest
pair
mutualist
relationship
may
promot
colon
facilit
surviv
within
urt
although
studi
provid
extens
dataset
composit
urt
microbiom
sequenc
subset
sampl
identifi
bacteri
phylotyp
recov
cultur
highlight
extens
cultur
method
use
identifi
bacteria
abl
detect
bacteri
group
via
sequenc
howev
method
distinguish
viabl
bacteria
uncultur
organ
may
viabl
sampl
nonetheless
sequenc
microbiota
becom
import
methodolog
advanc
bacteri
composit
assess
common
method
assess
composit
bacteri
commun
sequenc
rrna
gene
gene
nine
variabl
region
differ
allow
taxonom
identif
bacteria
classifi
oper
taxonom
unit
otu
gener
target
one
variabl
region
suffici
identifi
member
microbiota
genu
level
howev
specif
variabl
region
use
may
vari
due
tissu
type
particular
bacteri
famili
present
otu
help
quantit
overal
divers
microbiota
identif
beyond
genera
level
pose
signific
challeng
determin
exact
commun
composit
urt
exampl
urt
microbiota
contain
mani
member
genu
streptococcu
high
degre
sequenc
similar
genu
mean
possibl
resolv
rel
abund
member
genera
nonetheless
techniqu
extrem
use
character
composit
divers
urt
microbiota
sequenc
swab
middl
turbin
nasopharynx
anterior
nare
nasal
microbiota
tongu
buccal
mucosa
oral
caviti
sampl
identifi
corynebacteriacea
staphylococcacea
propionibacteriacea
domin
nasal
caviti
healthi
adult
although
consider
composit
variabl
individu
oral
caviti
healthi
adult
domin
streptococcacea
veillonellacea
microbi
commun
three
sampl
site
distinct
signifi
import
local
nich
colon
interestingli
separ
studi
determin
swab
repres
invas
surgic
sampl
suggest
less
invas
measur
adequ
nasal
microbi
studi
summari
commonli
found
bacteria
healthi
individu
present
tabl
colon
urt
begin
birth
importantli
earli
colon
event
impact
respiratori
health
throughout
life
correl
method
deliveri
ie
vagin
cesarean
breastfeed
suscept
respiratori
infect
asthma
allergi
observ
decad
believ
due
part
establish
urt
microbiom
recent
studi
bosch
et
al
demonstr
infant
born
via
cesarean
section
like
reduc
colon
level
protect
bacteria
includ
corynebacterium
dolosigranulum
speci
breastfeed
improv
infant
health
part
facilit
transfer
matern
antibodi
found
infant
nasal
secret
recent
studi
establish
role
exclus
breastfeed
versu
exclus
formula
feed
week
age
age
month
life
urt
microbiota
breastf
children
increas
level
corynebacterium
dolosigranulum
speci
may
play
import
role
protect
upper
respiratori
infect
furthermor
note
week
month
age
neg
correl
wheez
rel
abund
dolosigranulum
infant
colon
h
influenza
moraxella
catarrhali
pneumonia
within
first
month
life
like
demonstr
wheez
compar
colon
colon
statu
pathogen
year
life
correl
wheez
prospect
cohort
studi
involv
children
demonstr
nasopharyng
colon
streptococcu
month
age
strong
predictor
asthma
later
life
studi
also
demonstr
antibiot
use
within
week
sampl
increas
likelihood
colon
streptococcu
haemophilu
moraxella
import
composit
colon
bacteria
first
month
life
confirm
mous
model
allerg
asthma
mice
treat
antibiot
prior
wean
sever
allerg
asthma
antibiot
treatment
wean
effect
studi
microbi
success
perform
order
understand
develop
urt
microbiota
influenc
suscept
allerg
airway
diseas
recent
landmark
studi
biesbroek
et
al
investig
bacteri
success
pattern
infant
group
follow
cohort
infant
first
year
life
sampl
month
age
month
valid
find
studi
children
per
age
group
rel
bacteri
load
chang
time
howev
composit
microbiota
chang
time
month
age
five
cluster
observ
domin
either
streptococcu
moraxella
staphylococcu
corynebacterium
corynebacteriumdolosigranulum
streptococcu
staphylococcu
cluster
corynebacterium
dolosigranulum
found
low
abund
infant
progress
month
month
age
whose
microbiota
domin
moraxella
like
remain
domin
moraxella
infant
colon
corynebacteriumdolosigranulum
like
becom
domin
moraxella
contrast
microbi
commun
domin
streptococcu
staphylococcu
stabl
would
often
complet
differ
profil
subsequ
sampl
defin
pattern
interestingli
corynebacteriumdolosigranulum
cluster
highli
correl
breastfeed
furthermor
children
andor
urt
microbiota
less
like
urt
infect
compar
microbi
profil
studi
demonstr
repeat
pattern
ecolog
success
potenti
identifi
group
infant
may
risk
respiratori
infect
anoth
studi
assess
composit
nasopharyng
oral
microbiota
young
children
parent
cultur
rrna
sequenc
stearn
et
al
demonstr
oropharyng
swab
similar
microbi
commun
regardless
age
domin
streptococcu
prevotella
veillonella
adult
nasopharyng
sampl
domin
firmicut
includ
lachnospiracea
staphylococcu
streptococcu
speci
bacteroidet
sphingobacterium
prevotella
actinobacteria
corynebacterium
bifidobacterium
rothia
propionibacterium
contrast
children
domin
moraxella
haemophilu
enterobacteriacea
enterococcu
target
cultiv
bacteria
allow
speci
identif
includ
staphylococcu
st
epidermidi
haemophilu
h
influenza
haemophilu
parainfluenza
pigrum
corynebacterium
c
durum
c
mucifacien
furthermor
bacteri
cultur
identifi
increas
bacteri
densiti
nasopharynx
children
compar
healthi
adult
studi
demonstr
dramat
differ
infant
adult
urt
microbiota
suggest
progress
divers
yet
less
dens
commun
although
role
urt
microbiota
immun
system
develop
well
describ
gut
mechanist
evid
indic
microbiota
earli
life
contribut
suscept
colon
pathogen
recent
studi
demonstr
macrophag
recruit
urt
pneumococc
colon
decreas
infant
mice
due
inabl
creat
chemokin
gradient
within
nasal
caviti
model
neonat
microbiota
contribut
high
baselin
chemokin
express
antibiot
treatment
decreas
baselin
chemokin
express
allow
chemokin
gradient
form
upon
pneumococc
exposur
understand
mechan
urt
microbiota
drive
earli
innat
immun
develop
suscept
colon
pathogen
excit
avenu
futur
research
mani
studi
describ
urt
microbiota
chang
older
adult
evid
chang
may
contribut
increas
suscept
respiratori
infect
exampl
children
colon
pneumonia
occur
frequent
gener
asymptomat
howev
colon
appropri
control
dissemin
nasopharynx
may
result
pneumonia
mening
septicemia
young
adult
colon
less
frequent
shorter
durat
due
adequ
immun
control
consequ
diseas
rare
unless
complic
comorbid
influenza
infect
dynam
carriag
elderli
well
studi
howev
adult
carriag
rate
low
combin
low
colon
rate
high
incid
pneumonia
impli
colon
brief
proce
swiftli
infect
support
peak
invas
pneumococc
diseas
elderli
occur
christma
holiday
contact
grandchildren
major
reservoir
pneumonia
presum
occur
furthermor
mous
model
indic
pneumonia
colon
urt
microbiota
profoundli
distinct
age
mice
fail
return
microbiota
composit
similar
prepneumococc
exposur
younger
mice
abl
whether
chang
microbiota
contribut
permiss
infect
clear
although
preliminari
studi
support
hypothesi
nasopharyng
microbiota
older
adult
appear
undergo
profound
chang
anterior
nare
adult
year
old
distinct
oropharynx
distinct
lost
elderli
year
old
becom
domin
streptococcu
prevotella
veillonella
suggest
structur
microbi
commun
may
degrad
age
facilit
expans
streptococc
speci
exampl
shannon
divers
increas
elderli
patient
suffer
pneumonia
compar
healthi
elderli
peopl
shannon
divers
index
metric
account
abund
differ
bacteria
low
shannon
divers
suggest
microbiota
domin
bacteri
speci
wherea
high
shannon
divers
suggest
mani
differ
taxa
even
rel
abund
pneumonia
patient
distinct
decreas
anaerob
bacteria
includ
prevotella
decreas
lactic
acid
bacteria
leptotrichia
increas
viral
load
human
experiment
pneumococc
carriag
model
identifi
increas
shannon
divers
urt
microbiota
correl
colon
permiss
phenotyp
mous
model
pneumonia
also
implic
role
dysbiosi
howev
distinct
microbi
interact
could
occur
yet
fulli
elucid
whether
specif
bacteri
speci
overal
microbi
commun
dynam
import
suscept
diseas
elderli
still
unknown
fig
immunosenenesc
defin
chang
immun
function
major
contribut
factor
increas
incid
respiratori
infect
peopl
year
old
unclear
immunosenesc
affect
composit
mainten
urt
microbiota
although
associ
immun
statu
dysbiosi
intestin
microbiota
impair
innat
immun
urt
describ
elderli
mous
model
exampl
express
murin
cathelicidin
decreas
recruit
macrophag
respons
pneumococc
colon
contribut
decreas
clearanc
bacteria
elderli
mice
recent
tumor
necrosi
factor
tnf
shown
elev
elderli
mice
promot
prematur
monocyt
egress
bone
marrow
impair
bacteri
clearanc
upon
reach
nasopharynx
data
correl
well
human
data
demonstr
elev
level
circul
associ
increas
risk
pneumonia
season
pattern
respiratori
infect
well
document
pneumonia
preval
winter
earli
spring
month
northern
hemispher
infant
highest
preval
pneumonia
nasopharyng
colon
cooler
drier
month
worldwid
number
factor
propos
may
contribut
increas
infect
risk
winter
includ
increas
crowd
decreas
immun
expos
colder
air
studi
assess
children
year
old
found
season
affect
pneumococc
pneumonia
invas
pneumococc
diseas
invas
pneumococc
diseas
increas
autumn
correl
go
back
school
wherea
pneumonia
case
increas
winter
furthermor
children
carri
higher
densiti
pneumonia
winter
month
health
care
profession
asymptomat
carriag
variou
pathogen
differ
winter
summer
high
catarrhali
coronaviru
winter
high
klebsiella
pneumonia
summer
whether
season
chang
urt
microbiota
also
contribut
infect
risk
unclear
bogaert
et
al
found
increas
rel
abund
proteobacteria
winter
month
increas
carrier
fusobacteria
cyanobacteria
although
unknown
whether
affect
respiratori
infect
infant
respiratori
infect
increas
carriag
rate
haemophilu
period
decreas
moraxella
carriag
period
monitor
chang
dynam
within
urt
microbiota
may
elucid
import
interact
occur
differ
humid
temperatur
condit
exposur
cigarett
smoke
whether
activ
passiv
exposur
contribut
chronic
respiratori
diseas
eg
asthma
chronic
obstruct
pulmonari
diseas
copd
acut
respiratori
infect
cigarett
smoke
increas
infiltr
inflammatori
immun
cell
decreas
mucociliari
clearanc
upper
lower
respiratori
tract
ultim
lead
bacteri
colon
infect
smoker
increas
microbi
divers
compar
nonsmok
smoker
increas
likelihood
carri
pathogen
includ
pneumonia
streptococcu
pyogen
h
influenza
catarrhali
consist
smoker
less
carriag
nonpathogen
streptococcu
prevotella
peptostreptococcu
speci
shown
invers
correl
presenc
pathogen
smoker
larg
increas
carriag
sever
bacteria
includ
associ
endocard
urt
infect
nasopharynx
suggest
increas
risk
invas
diseas
due
increas
carriag
pathogen
bacteria
addit
mice
expos
cigarett
smoke
concurr
pneumonia
nasopharyng
colon
heighten
invas
pneumococc
diseas
compar
room
mice
correl
impair
innat
immun
respons
support
impair
innat
immun
colon
resist
like
contribut
exacerb
copd
oral
microbiota
also
shown
affect
cigarett
smoke
smoke
increas
rel
abund
megasphaera
speci
associ
periodont
decreas
peptostreptococcu
shown
inhibit
growth
variou
urt
pathogen
vitro
cigarett
smoke
demonstr
affect
bacteri
adher
oral
tissu
cigarett
smoke
may
also
affect
carriag
infect
alter
bacteria
directli
exampl
biofilm
format
immun
evas
increas
st
aureu
cation
antimicrobi
peptid
includ
cathelicidin
reli
membran
charg
target
form
pore
bacteri
membran
cigarett
smoke
extract
modul
surfac
charg
st
aureu
thu
reduc
lysi
effect
limit
tradit
cigarett
smoke
electron
cigarett
smoke
vapor
increas
virul
biofilm
format
decreas
bacteri
kill
impair
epitheli
alveolar
kill
st
aureu
collect
smoke
demonstr
affect
multipl
facet
urt
microbiota
includ
host
defens
bacteri
adher
colon
well
pathogen
virul
chronic
rhinosinus
inflammatori
disord
sinus
last
greater
week
microbi
dysbiosi
defin
alter
microbi
commun
believ
associ
diseas
suscept
patholog
featur
chronic
rhinosinus
contrast
condit
eg
smoke
age
increas
microbi
divers
decreas
microbi
divers
report
chronic
rhinosinus
patient
decreas
divers
may
due
increas
preval
anaerob
bacteria
believ
thrive
result
increas
preval
anaerob
pocket
occur
biofilm
format
presenc
corynebacterium
speci
correl
optim
surgic
outcom
provid
evid
corynebacterium
benefici
member
urt
microbiota
genet
diseas
affect
mucociliari
clearanc
cystic
fibrosi
primari
ciliari
dyskinesia
affect
urt
microbiota
two
recent
studi
identifi
infant
cystic
fibrosi
result
thicken
mucu
layer
alter
urt
microbiota
develop
compar
healthi
infant
includ
increas
rel
abund
staphylococcu
speci
decreas
abund
potenti
benefici
bacteria
mani
peopl
primari
ciliari
dyskinesia
combin
diseas
result
decreas
ciliari
action
clear
mucu
also
suffer
chronic
rhinosinus
high
report
rate
urt
manifest
diseas
contribut
morbid
studi
complet
assess
urt
microbiota
patient
increas
number
infect
antibiot
exposur
like
alter
composit
monitor
urt
microbiota
patient
impair
mucociliari
clearanc
may
result
decreas
prevent
lung
infect
suscept
popul
strongest
evid
interspeci
competit
st
aureu
pneumonia
vivo
come
studi
urt
microbiota
chang
pneumococc
vaccin
studi
demonstr
pneumonia
carriag
nasopharynx
decreas
carriag
rate
st
aureu
increas
due
part
bactericid
compon
produc
pneumonia
hydrogen
peroxid
hydrogen
peroxid
product
induc
dna
damag
st
aureu
trigger
releas
resid
prophag
result
death
st
aureu
strain
st
aureu
produc
catalas
carotenoid
staphyloxanthin
reduc
damag
effect
peroxid
neutrophil
kill
compensatori
defens
mechan
fact
strain
st
aureu
carri
lysogen
phage
may
explain
studi
find
invers
relationship
st
aureu
pneumonia
immun
statu
host
also
contribut
appar
invers
relationship
carriag
mous
model
shown
antibodi
pneumonia
dehydrogenas
st
aureu
block
subsequ
st
aureu
colon
similarli
reciproc
relationship
pneumonia
st
aureu
occur
children
carri
equal
level
pathogen
simultan
impli
fulli
compet
immun
system
influenc
carriag
staphylococcu
aureu
h
influenza
posit
correl
margoli
et
al
demonstr
level
h
influenza
higher
st
aureu
initi
colon
rat
nasopharynx
possibl
due
liber
nutrient
toxin
releas
st
aureu
disrupt
erythrocyt
includ
nad
hemin
howev
st
aureu
invers
relationship
sever
microbi
commun
member
describ
invers
correl
corynebacterium
speci
st
aureu
uehara
et
al
appli
corynebacterium
nare
st
aureu
carrier
result
erad
st
aureu
carrier
significantli
receiv
st
epidermidi
salt
solut
mechan
staphylococcu
epidermidi
corynebacterium
speci
st
aureu
occupi
similar
nich
urt
nich
competit
control
product
peptid
includ
bacteriocin
differ
speci
either
impact
viabil
biofilm
format
bacteriocin
normal
peptid
produc
bacteria
target
usual
similar
bacteria
st
epidermidi
strain
produc
extracellular
serin
proteas
esp
inhibit
biofilm
format
nasal
colon
st
aureu
st
epidermidi
esp
disrupt
biofilm
format
sever
differ
strain
st
aureu
includ
cocultur
year
suggest
resist
develop
strain
place
nasal
caviti
st
aureu
carrier
colon
strain
saw
reduct
erad
st
aureu
furthermor
disrupt
st
aureu
biofilm
facilit
kill
human
previous
resist
strain
competit
st
epidermidi
st
aureu
clearli
involv
bacteri
host
interact
intens
intraspeci
competit
featur
streptococcu
genera
mediat
larg
part
bacteriocin
peptid
target
similar
bacteria
usual
coexpress
immun
peptid
protect
produc
bacteria
recent
studi
assess
pneumonia
genom
found
uniqu
combin
bacteriocin
across
differ
strain
suggest
dynam
complex
interact
strain
product
hydrogen
peroxid
pneumonia
allow
antagon
mani
bacteria
howev
bacteri
member
urt
possess
pathway
compet
pneumonia
h
influenza
pneumonia
cocolon
nasopharynx
healthi
children
competit
rampant
two
speci
h
influenza
caus
rapid
decreas
pneumonia
carriag
within
day
cocolon
immunocompromis
mice
interestingli
recruit
neutrophil
activ
peptidoglycan
h
influenza
enhanc
kill
pneumonia
pneumonia
impair
fit
h
influenza
neisseria
meningitidi
produc
neuraminidas
cleav
sialic
acid
bacteria
use
evad
detect
immun
system
vitro
studi
also
suggest
differ
bacteria
support
hinder
pneumonia
growth
pneumonia
abil
respond
peptid
nasopharyng
bacteria
includ
prevotella
speci
activ
transcript
import
colon
factor
contrast
corynebacterium
speci
seem
impair
persist
pneumonia
recent
demonstr
c
accolen
abil
promot
kill
pneumonia
metabol
triacylglycerol
present
urt
epithelium
produc
oleic
linol
acid
toxic
pneumonia
human
pneumonia
carriag
model
develop
assess
relev
factor
involv
colon
approxim
intranas
expos
pneumonia
success
colon
establish
pneumococc
carriag
correl
carriag
st
aureu
catarrhali
h
influenza
although
subtl
decreas
st
aureu
carriag
time
increas
shannon
divers
increas
likelihood
colon
st
nasopharyng
sampl
less
like
colon
furthermor
success
colon
link
increas
viral
carriag
urt
colon
mani
differ
potenti
pathogen
constantli
expos
environment
bacteria
compet
nich
surviv
pathogen
surviv
thrive
infant
elderli
nasal
oral
caviti
like
due
synerg
loss
colon
resist
alter
innat
adapt
immun
earli
colon
event
includ
birth
rout
breastfeed
exposur
children
influenc
acquisit
success
urt
microbiota
corynebacterium
dolosigranulum
speci
repeatedli
demonstr
protect
profil
diseas
futur
work
establish
earli
colon
event
method
help
prevent
acut
chronic
airway
diseas
throughout
lifespan
limit
mechanist
studi
complet
describ
benefici
microbi
colon
interact
immun
system
urt
recent
work
identifi
specif
bacteri
group
nasal
caviti
associ
efficaci
vaccin
influenza
suggest
nasal
immun
may
regul
nasal
microbiota
explor
interact
uncov
gut
includ
adapt
immun
develop
pathogen
clearanc
could
greatli
decreas
respiratori
diseas
morbid
fecal
transplant
use
combat
recurr
clostridium
difficil
infect
diarrhea
identifi
boost
colon
resist
pathogen
alter
microbi
commun
colon
resist
caus
limit
nutrient
essenti
pathogen
growth
disrupt
nich
requir
pathogen
enhanc
immun
respons
bodi
take
advantag
colon
resist
begin
explor
urt
bacteri
viral
pathogen
urt
requir
uniqu
nich
thu
variou
microbi
commun
may
requir
resist
differ
pathogen
develop
human
anim
model
assess
intramicrobiota
competit
interact
excit
avenu
develop
target
probiot
futur
combat
respiratori
pathogen
requir
thorough
understand
dynam
urt
microbiota
interact
host
lp
mg
dmeb
contribut
write
critic
review
manuscript
